Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02624
Species: Homo sapiens
Position : chr13:28840000-28850000
Year: 2023
Title: Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: KMT2A-rearranged acute lymphoblastic leukemia
PMID:  38016946
MONDO: MONDO:0035941
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: SEM
CVCL ID: CVCL_0095
Cell Type: precursor B cell
Cell Ontology ID: CL:0000817
Experiment Type: Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin interaction assay
High Throughput Method: noncoding CRISPR screen; HOXA9 ChIP-seq; MEIS1 ChIP-seq; ATAC-seq; RNA-seq; Hi-C; Capture-C; ChIP-seq
Low Throughput Method: Cas9 enhancer editing; CRISPRi; RT-qPCR; Western blot; competitive proliferation assay; FLT3 cDNA rescue; flow cytometry; NSG transplantation
About Target Gene
Target gene : FLT3
About TF
TF name : HOXA9
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
HOXA9 TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_02625 chr13:28840000-28850000 blood precursor B cell KMT2A-rearranged acute lymphoblastic leukemia
E_03831 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
E_03832 chr13:28843000-28843500 bone marrow B-lymphoblast B-cell acute lymphoblastic leukemia
E_03867 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
E_03868 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
E_03869 chr13:28843000-28843500 bone marrow B-lymphoblast B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer